Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide-Reference-Cited by-同舟云学术

Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide

Published:2004-07 Issue:7 Volume:48 Page:2693-2696
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Wu Chang-Jer¹,Jan Jia-Tsrong¹,Chen Chi-Min²,Hsieh Hsing-Pang³,Hwang Der-Ren³,Liu Hwan-Wun¹,Liu Chiu-Yi¹,Huang Hui-Wen¹,Chen Su-Chin¹,Hong Cheng-Fong¹,Lin Ren-Kuo³,Chao Yu-Sheng³,Hsu John T. A.³

Affiliation:

1. Institute of Preventive Medicine, National Defense Medical College, National Defense University

2. Animal Technology Institute Taiwan, Miaoli, Taiwan

3. Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei

Abstract

ABSTRACT Antiviral agents are urgently needed to fight severe acute respiratory syndrome (SARS). We showed that niclosamide, an existing antihelminthic drug, was able to inhibit replication of a newly discovered coronavirus, SARS-CoV; viral antigen synthesis was totally abolished at a niclosamide concentration of 1.56 μM, as revealed by immunoblot analysis. Thus, niclosamide represents a promising drug candidate for the effective treatment of SARS-CoV infection.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.48.7.2693-2696.2004

Reference9 articles.

1. Centers for Disease Control and Prevention. 2003. Update: severe acute respiratory syndrome—United States, June 18, 2003. Morb. Mortal. Wkly. Rep.52:570.

2. Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in Culture

3. Katz, M. 1977. Anthelmintics. Drugs13:124-136.

4. Ksiazek, T. G., D. Erdman, C. S. Goldsmith, S. R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J. A. Comer, W. Lim, P. E. Rollin, S. F. Dowell, A. E. Ling, C. D. Humphrey, W. J. Shieh, J. Guarner, C. D. Paddock, P. Rota, B. Fields, J. DeRisi, J. Y. Yang, N. Cox, J. M. Hughes, J. W. LeDuc, W. J. Bellini, and L. J. Anderson. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med.348:1953-1966.

5. Lee, N., D. Hui, A. Wu, P. Chan, P. Cameron, G. M. Joynt, A. Ahuja, M. Y. Yung, C. B. Leung, K. F. To, S. F. Lui, C. C. Szeto, S. Chung, and J. J. Sung. 2003. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med.348:1986-1994.

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. On the origins of SARS-CoV-2 main protease inhibitors;RSC Medicinal Chemistry;2024

2. Repurposing antiparasitic drugs for the treatment of other diseases;Advances in Antiparasitic Therapies and Drug Delivery;2024

3. Niclosamide, but not ivermectin, inhibits anoctamin 1 and 6 and attenuates inflammation of the respiratory tract;Pflügers Archiv - European Journal of Physiology;2023-11-18

4. Potential Target Discovery and Drug Repurposing for Coronaviruses: Study Involving a Knowledge Graph–Based Approach;Journal of Medical Internet Research;2023-10-20

5. Niclosamide as a chemical probe for analyzing SARS-CoV-2 modulation of host cell lipid metabolism;Frontiers in Microbiology;2023-10-11